G-단백질 결합 수용체 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The G-Protein Coupled Receptors Market size is expected to reach USD 7.65 Billion in 2034 from USD 4.28 Billion (2025) growing at a CAGR of 6.67% during 2026-2034.

The global G-protein coupled receptors (GPCR) market is witnessing significant growth due to its critical role in drug discovery and development. GPCRs represent one of the largest classes of drug targets, influencing a wide range of physiological processes. Increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has accelerated research activities focused on GPCR-based therapeutics.

Key drivers include advancements in molecular biology, bioinformatics, and high-throughput screening technologies that enable efficient identification of GPCR targets. Pharmaceutical companies are heavily investing in R&D to develop novel drugs targeting these receptors. Additionally, growing collaborations between academic institutions and biotech firms have enhanced innovation and expanded the application scope of GPCRs.

Looking ahead, the market is expected to grow with the integration of artificial intelligence and computational drug design techniques. Personalized medicine and targeted therapies will further boost demand for GPCR-based drugs. As research continues to uncover new receptor functions, the market will remain highly dynamic, offering significant opportunities for innovation and therapeutic advancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Cell Lines
• Detection Kits
• Cell Culture Reagents
• Ligands

By Assay Type

• cAMP Functional Assays
• Calcium Functional Assays
• B-Arrestin Functional Assays
• Radioligand Binding & GTPYS Functional Assays
• Internalization Assays
• Trafficking Assays
• Other Assays

By Application

• Cancer Research
• CNS Research
• Metabolic Research
• Cardiovascular Research
• Respiratory Research
• Inflammation Research
• Other Applications

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Eurofins Scientific, QIAGEN, WuXi AppTec, Promega Corporation, Abcam plc, Merck KGaA, PerkinElmer Inc, Enzo Biochem Inc, BD
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Cell Lines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Detection Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cell Culture Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Ligands Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET: BY ASSAY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Assay Type
• 5.2. cAMP Functional Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Calcium Functional Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. B-Arrestin Functional Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Radioligand Binding & GTPYS Functional Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Internalization Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Trafficking Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CNS Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Metabolic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Respiratory Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Inflammation Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Assay Type
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Assay Type
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Assay Type
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Assay Type
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Assay Type
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL G-PROTEIN COUPLED RECEPTORS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Eurofins Scientific
  • 9.2.3 QIAGEN
  • 9.2.4 WuXi AppTec
  • 9.2.5 Promega Corporation
  • 9.2.6 Abcam Plc
  • 9.2.7 Merck KGaA
  • 9.2.8 PerkinElmer Inc
  • 9.2.9 Enzo Biochem Inc
  • 9.2.10 BD